[1] Tolba M. S., Kamal El‐Dean A. M., Ahmed M., and Hassanien R. (2019) Synthesis, reactions, and biological study of some new thienopyrimidine derivatives as antimicrobial and anti‐inflammatory agents. J. Chin. Chem. Soc., 66 (5) 548-557. [2] Tolba M. S., Al‐Hossainy A. F., Kamal Eldean A. M., and Younis O. (2022) From blue to green photoluminescence: design, synthesis, and DFT calculations of heterocyclic compounds containing chromenothienopyrimidine moiety. Asian J. Org. Chem., 11 (3) e202100801. [3] El-Gaby M. S. A., Hussein M. F., Faraghally F. A., Drar A. M., and Gad M. A. (2023) Insecticidal activity and structure activity relationship study of some synthesized hydrazone, dihydropyridine and 3-cyano-1, 4-dihydro-pyradazin-4-one derivatives against Aphis nerii. Curr Chem Lett, 12 (3) 599-606. [4] Gad M. A., Bakry M. M., Tolba E. F., Alkhaibari A. M., Mashlawi A. M., Thabet M. A., Al-Taifi E. A., and Bakhite E. A. (2024) Exploration of some heterocyclic compounds containing trifluoromethylpyridine scaffold as insecticides toward Aphis gossypii insects. Chem. Biodivers., 21 (6) e202400451. [5] Abd El‐Lateef H. M., Khalaf M. M., Gouda M., Gad M. A., Abdelhamid A. A., Ismail A. F., Amer A. A., and Drar A. M. (2024) Synthesis and Insecticidal Evaluation of 3, 5‐Dicyanopyridines Against Cotton Aphids via Microwave‐Assisted Multicomponent Reactions. Chem. Biodivers., 21 (4) e202400218. [6] Atif A., El Alami A., and Ait Sir H. (2025) Minireview of Synthesis Process of 1, 3, 4-Thiadiazole Derivatives. Chem. Afr., 8 (7) 2663-2686. [7] Atif A., and Ait Sir H. (2025) Progress in the Synthesis of Tetrazoles. A Brief Review. Org. Prep. Proced. Int., 1-16. [8] Al-Mulla A. (2017) A review: biological importance of heterocyclic compounds. Der Pharma Chemica, 9 (13) 141-147. [9] El-Ossaily Y., Alanazi N., Althobaiti I., Altaleb H., Al-Muailkel N., El-Sayed M., Hussein M. F., Ahmed I. M., Alnazi M. M., Fawzy A., Abdel-Raheem S. A. A., and Tolba M. (2024) Multicomponent approach to the synthesis and spectral characterization of some 3, 5-pyrazolididione derivatives and evaluation as anti-inflammatory agents. Curr. Chem. Lett., 13 (1) 127-140. [10] Abdel-Raheem S. A., Fouad M. R., Gad M. A., El-Dean A. M. K., and Tolba M. S. (2023) Environmentally green synthesis and characterization of some novel bioactive pyrimidines with excellent bioefficacy and safety profile towards soil organisms. J. Environ. Chem. Eng., 11 (5) 110839. [11] Sebaiy M. M., El-Adl S. M., Nafea A., Mattar A. A., Abdul-Malik M. A., Abdel-Raheem S. A., and Elbaramawi S. S. (2024) Review: Instrumental Analytical techniques for Evaluating some Anti-infective Drugs in Pharmaceutical Products and Biological Fluids. Curr. Chem. Lett, 13 (3) 491-502. [12] Gad M. A., Bakry M. M. S., Shehata E. A., and Dabour N. A. (2023) Insecticidal thioureas: Preparation and biochemical impacts of some novel thiobenzamide derivatives as potential eco-friendly insecticidal against the cotton leafworm, Spodoptera littoralis (Boisd.). Curr. Chem. Lett, 12 (4) 685-694. [13] El-Gaby M. S. A., Bakry M. M. S., Hussein M. F., Faraghally A. F., Khalil A. M., Gad M. A., and Drar A. M. (2023) Insecticidal efficacy and structure-activity relationship study of some synthesized cyanobenzylidene and bisbenzylidene derivatives against Aphis nerii. Curr. Chem. Lett, 12(3) 529-536. [14] Varala R., Kurra M., Amanullah M., Hussien M., and Alam M. M. (2024) Recent methods in the synthesis of chromeno [2, 3-d] pyrimidines. Chem. Heterocycl. Compd., 60 (3) 111-117. [15] Chaban T. I., Klenina O. V., Chaban I. H., and Lelyukh M. I. (2024) Recent advances in the synthesis of thiazolo [4, 5-b] pyridines. Part 2: Focus on thiazole annulation to pyridine ring (microreview). Chem. Heterocycl. Compd., 60 (3) 130-132. [16] Jasiński R. (2024) Synthesis of 1, 2-oxazine N-oxides via noncatalyzed hetero-Diels–Alder reactions of nitroalkenes (microreview). Chem. Heterocycl. Compd., 60 (3) 121-123. [17] Thakur D., Kumar V., Tyagi S.K., and Parmar R.S., (2023) A Review on the Medicinal Significance of Heterocyclic Compounds. Int. j. res. appl. sci. eng. technol. 11 (6) 1-9. [18] Malek F., Harit T., Cherfi M., and Kim B. (2022) Insights on the synthesis of n-heterocycles containing macrocycles and their complexion and biological properties. Molecules, 27 (7) 2123. [19] Awasthi A., Rahman M. A., and Bhagavan Raju M. (2023) Synthesis, in silico studies, and in vitro anti-inflammatory activity of novel imidazole derivatives targeting P38 MAP kinase. ACS omega, 8 (20) 17788-17799. [20] Marinescu M. (2023) Benzimidazole-triazole hybrids as antimicrobial and antiviral agents: A systematic review. Antibiotics, 12 (7) 1220. [21] Khan S., Hussain R., Khan Y., Iqbal T., Chinnam S., Akif M., and Dera A. A. (2024) Hybrid benzothiazole derived fused triazole/thiazole derivatives as versatile anti-Alzheimer agents: Synthesis, characterization, biological evaluation and molecular docking studies. J. Mol. Struct., 1318 (2024) 139200. [22] Cherfi M., Harit T., Amanchar M., Oulous A., and Malek F. (2024) An Overview of Pyrazole-Tetrazole-Based Hybrid Compounds: Synthesis Methods, Biological Activities and Energetic Properties. Organics, 5 (4) 575-597. [23] Cherfi M., Dib I., Harit T., Ziyyat A., and Malek F. (2021) Synthesis and characterization of new pyrazole–tetrazole derivatives as new vasorelaxant agents. Drug Dev. Res., 82 (7) 1055-1062. [24] Qadir T., Amin A., Sharma P.K., Jeelani I., and Abe H. (2022) A review on medicinally important heterocyclic compounds. Open J. Med. Chem., 16 (1) e187410452202280 [25] Baynes H. W. (2015) Classification, pathophysiology, diagnosis and management of diabetes mellitus. J diabetesmetab, 6 (5) 1-9. [26] Daoudi N. E., Bouziane O., Bouhrim M., and Bnouham M. (2022) Natural aldose reductase inhibitors for treatment and prevention of diabetic cataract: A review. Herba Pol., 68 (1) 35-58. [27] Daoudi N. E., Bouhrim M., Bouziane O., Abdnim R., Bouknana S., Elrherabi A., Mekhfi H., Aziz M., Legssyer A., Ziyyat A., and Bnouham M. (2023) Acute and Subchronic Treatment of Roasted and Unroasted Argan Oil on Postprandial Glycemia and Its Effect on Glucose Uptake by Isolated Rat Hemidiaphragm. Lett. Drug Des. Discov., 20 (11) 1821-1829. [28] Marghich M., Daoudi N.E., Amrani O., Addi M., Hano C., Chen J.T., Mekhfi H., Ziyyat A., Bnouham M., and Aziz M. (2022) Antioxidant Activity and Inhibition of Carbohydrate Digestive Enzymes Activities of Artemisia campestris L. Front Biosci (Schol Ed)., 14 (4) 25. [29] Tseng C. H. (2004) The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol., 197 (2) 67-83. [30] Daoudi N.E., Bouhrim M., Ouassou H., Legssyer A., Mekhfi H., Ziyyat A., Aziz M., and Bnouham M. (2020) Inhibitory effect of roasted/ unroasted Argania spinosa seeds oil on α- glucosidase, α-amylase and intestinal glucose absorption activities. S. Afr. J., 135 (2020) 413-420. [31] Jayaraj S., Suresh S., and Kadeppagari R. K. (2013) Amylase inhibitors and their biomedical applications. Starch‐Stärke, 65 (7‐8) 535-542. [32] Atmaram U. A., and Roopan S. M. (2022) Biological activity of oxadiazole and thiadiazole derivatives. Appl. Microbiol. Biotechnol., 106 (9) 3489-3505. [33] Sultana R., Ali A., Rana M., Ahmad I., Kamthan M., Almuqdadi H. T. A., Mehandi R., Abid M., and El-Bahy Z. M. (2024) Synthesis of oxadiazole derivatives: Anti-bacterial, DNA binding and in silico molecular modelling approaches. J. Mol. Struct., 1318 (2024) 139350. [34] Mendes Araujo H., de Moura G. A., Mendes Rocha Y., Viana Rodrigues J. P., and Nicolete R. (2023) Oxadiazole Derivatives as Anticancer and Immunomodulatory Agents: A Systematic Review. Curr. Med. Chem., 30 (30) 3472-3485. [35] Veeramani V., Ganesh P. S. P., Bharanidharan S., Muthuraja P., Govindasamy C., and Rajamohan R. (2024) 2, 5-Disubstituted structures of 1, 3, 4-oxadiazole and 1, 3, 4-thiodiazole for anti-inflammatory potential: DFT approach for the structural aspects. J. Mol. Struct., 1318 (2024) 139263. [36] Gupta O., Chawla G., and Pradhan T. (2024) 1, 3, 4-oxadiazole scaffold in antidiabetic drug discovery: an overview. Mini-Rev. Med. Chem., 24 (20) 1800-1821. [37] Patidar M., Dubey R., Minz S., Pradhan M., and Deshmukh N. (2025) A mechanism-driven strategy for in-silico prediction, molecular docking, synthesis, and biological assessment of substituted 1, 3, 4-oxadiazole derivatives as novel antidiabetic agents. J. Appl. Pharm. Res., 13 (2) 194-203. [38] Bhat N., Kumar A., Adiga M. C., and KR K. (2025) DESIGN, SYNTHESIS, AND ANTIDIABETIC EVALUATION OF SOME NEW COUMARIN-INCORPORATED 1, 3, 4-OXADIAZOLE-2-THIOL DERIVATIVES. Rasayan J. Chem., 18 (2) 805-811 [39] Hosangadi B.D., and Dave R.H. (1996) An efficient general method for esterification of aromatic carboxylic acids. Tetrahedron Lett., 37 (35) 6375-6378. [40] 1. Shekarchi M., Navidpour L., Khorami A. R., Partoazar A., Shafaroodi H., Rahmanipour N., and Shekarchi M. (2011) Synthesis of N-arylidene-2-(2-phenoxyphenyl) acetohydrazides as anti-inflammatory agents. Iran. J. Pharm. Res., 10 (2) 369. [41] Galal S. A., Hegab K. H., Kassab A. S., Rodriguez M. L., Kerwin S. M., El-Khamry A. M. M. A., and El Diwani H. I. (2009) New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity. Eur. J. Med. Chem., 44 (4) 1500-1508. [42] Rashid M., Husain A., Mishra R., Karim S., Khan S., Ahmad M.,Al-wabel N., Husain A., Ahmad A., and Khan S. A. (2019) Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents. Arab. J. Chem., 12 (8) 3202-3224. [43] Atif A., Zahm S., Jebbari S., El Alami A., Youssoufi F., Ait Sir H., Kerraj S., and Salah, M. (2023) synthesis, admet, docking and molecular dynamics of new molecules derivatives from 1,3,4-oxadiazole and 1,3,4-bisoxadiazole: new compounds against hiv. Eur. Chem. Bull., 12 (12) 4139 – 4156 [44] Atif A., Ameur S., Bendaoud A., Hsissou R., Jebbari S., Ait Sir H., and Salah M. (2025) Comprehensive evaluation of a benzimidazole-1,3,4-oxadiazole derivative for corrosion protection of C38 steel in HCl: Experimental, molecular dynamics, monte carlo, and in silico pharmacokinetic approaches. Curr. Chem. Lett., 14 (2025) 777-792 [45] Yang J. M., and Chen C. C. (2004) GEMDOCK: a generic evolutionary method for molecular docking. Proteins:Struct., Funct., Bioinf., 55 (2) 288-304. [46] Daina A., Michielin O., and Zoete V. (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 7 (1) 42717. [47] Banerjee P., Eckert A. O., Schrey A. K., and Preissner R. (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res., 46 (1) 257-263. [48] Pires D. E., Blundell T. L., and Ascher D. B. (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem., 58 (9) 4066-4072. [49] Amir M., and Shikha K. (2004) Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2, 6-dichloroanilino) phenyl] acetic acid derivatives. Eur. J. Med. Chem., 39 (6) 535-545. [50] Li D. J., Dan F. J., and Fu H. Q. (2008) Synthesis and antibacterial activities of 1, 3-bis [3-n-acetyl-2-aryl-1,3,4-oxadiazoline-5-yl] benzenes. Heterocycl. Commun., 14 (1-2) 101-106. [51] Atif A., El Alami A., Youssoufi F., Jebbari S., and Ait Sir H. (2025) Review of synthesis process of 1,3,4-oxadiazole analogs. Curr. Chem. Lett., 14 (2025) 339–364 [52] Atif A., Ameur S., and Ait Sir H. (2025) Synthesis, characterization and in silico evaluation of 2,5-bis(2-(trifluoromethyl)-1Hbenzimidazol-5-yl)-1,3,4-oxadiazole: Reactivity, ADME/toxicity, and docking against therapeutic targets. Curr. Chem. Lett., 14 (2025) 793-804 [52] Jha K. K., Samad A., Kumar Y., Shaharyar M., Khosa R. L., Jain J., Kumar V., and Singh P. (2010) Design, synthesis and biological evaluation of 1, 3, 4-oxadiazole derivatives. Eur. J. Med. Chem., 45 (11) 4963-4967. [53] Jakopin Z., and Dolec M. S. (2008) Recent Advances in the Synthesis of 1, 2, 4-and 1, 3, 4-Oxadiazoles. Curr. Org. Chem., 12 (10) 850-898. [54] Yadav D., Bodke S., Biradar A., and Kenchappa R. (2016) Synthesis, characterization and biological evaluation of 2-(2-substituted)-5-phenyl-1, 3, 4-oxadiazole and 3, 6-diphenyl [1, 2, 4] triazole [3, 4][1, 3, 4] thiadiazole derivatives. Ind J Adv Chem Sci., 4 (2016) 269-275. [55] Kaur N., Kumar V., Nayak S. K., Wadhwa P., Kaur P., and Sahu S. K. (2021) Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review. Chem. Biol. Drug Des., 98 (4) 539-560. [56] Nawaz M., Taha M., Qureshi F., Ullah N., Selvaraj M., Shahzad S., Chigurupati S., Waheed A., and Almutairi F. A. (2020) Structural elucidation, molecular docking, α-amylase and α-glucosidase inhibition studies of 5-amino-nicotinic acid derivatives. BMC chem., 14 (1) 1-11. [57] Altaff S. M., Raja Rajeswari T., and Subramanyam, C. (2020) Synthesis, α-amylase inhibitory activity evaluation and in silico molecular docking study of some new phosphoramidates containing heterocyclic ring. Phosphorus Sulfur Silicon Relat. Elem., 196 (4) 389-397. [58] Khirallah S. M., Ramadan H. M., Aladl H. A. A., Ayaz N. O., Kurdi L. A., Jaremko M., Alshawwa S. Z., and Saied E. M. (2022) Antidiabetic potential of novel 1, 3, 5-trisubstituted-2-thioxoimidazloidin-4-one analogues: Insights into α-glucosidase, α-amylase, and antioxidant activities. Pharmaceuticals, 15 (12) 1576. [59] Saddique F. A., Ahmad M., Ashfaq U. A., Muddassar M., Sultan S., and Zaki M. E. (2022) Identification of cyclic sulfonamides with an N-arylacetamide group as α-glucosidase and α-amylase inhibitors: biological evaluation and molecular modeling. Pharmaceuticals, 15 (1) 106. [60] Harit T., Cherfi M., Elhouda Daoudi N., Isaad J., Bnouham M., and Malek F. (2022) Hybrid Pyrazole‐Tetrazole Derivatives with High α‐Amylase Inhibition Activity: Synthesis, Biological Evaluation and Docking Study. ChemistrySelect, 7 (48) e202203757. [61] Qian M., Haser R., Buisson G., Duee E., and Payan F. (1994) The Active Center of a Mammalian. alpha.-Amylase. Structure of the Complex of a Pancreatic. alpha.-Amylase with a Carbohydrate Inhibitor Refined to 2.2-. ANG. Resolution. Biochemistry, 33 (20) 6284-6294. [62] Gupta S., Baweja G. S., Gupta G. D., and Asati V. (2023) Identification of potential N-substituted 5-benzylidenethiazolidine-2, 4 dione derivatives as α-amylase inhibitors: Computational cum synthetic studies. J. Mol. Struct., 1287 (2023) 135596. [63] Zala A. R., Naik H. N., Ahmad I., Patel H., Jauhari S., and Kumari P. (2023) Design and synthesis of novel 1, 2, 3-triazole linked hybrids: Molecular docking, MD simulation, and their antidiabetic efficacy as α-Amylase inhibitors. J. Mol. Struct., 1285 (2023) 135493. [64] Oulous A., Cherfi M., Daoudi N.E., Harit T., Yahyi A., Bnouham M., and Malek F. (2024) Synthesis, characterization and α-amylase inhibition activity of new family of tetrapodal ligands with pyrazole-tetrazole subunits. J. Mol. Struct.. 1321 (2025) 140254 [65] Knoll K. E., van der Walt M. M., and Loots D. T. (2022) In silico drug discovery strategies identified ADMET properties of decoquinate RMB041 and its potential drug targets against Mycobacterium tuberculosis. Microbiol. Spectr., 10 (2) e02315-21.